[Phe1ψ(CH2-NH)Gly2]nociceptin-(1-13)-NH2 is an agonist of the nociceptin (ORL 1) receptor

European Journal of Pharmacology

Volumn 349, Issue 1, 1998, Pages R5-

  Butour, Jean Luc ^a   Moisand, Christiane ^a   Mollereau, Catherine ^a   Meunier, Jean Claude ^a  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

cAMP synthesis inhibition; Human brain; Nociceptin pseudopeptide analog; Nociceptin receptor

Indexed keywords

CYCLIC AMP; FORSKOLIN; NOCICEPTIN; PSEUDOPEPTIDE; NOCICEPTIN (1 13) NH2, PHE(1) PSI(CH2 NH) GLY(2); NOCICEPTIN (1-13)-NH2, PHE(1)-PSI(CH2-NH)-GLY(2)-; NOCICEPTIN RECEPTOR; OPIATE PEPTIDE; OPIATE RECEPTOR; PEPTIDE FRAGMENT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL TRANSFORMATION; CHO CELL; DRUG ACTIVITY; FOOD INTAKE; GENE EXPRESSION; GUINEA PIG; HUMAN; HUMAN CELL; HUMAN TISSUE; MOTOR DYSFUNCTION; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; SPINAL ANESTHESIA; VAS DEFERENS; ANIMAL; BIOSYNTHESIS; CELL LINE; DRUG POTENTIATION; HAMSTER; METABOLISM;

ANIMALS; CELL LINE, TRANSFORMED; CHO CELLS; CRICETINAE; CYCLIC AMP; FORSKOLIN; HUMANS; OPIOID PEPTIDES; PEPTIDE FRAGMENTS; RECEPTORS, OPIOID;

EID: 0032523346     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00273-8     Document Type: Article

References (8)

1. Alvarez R., Daniels D.V. A separation method for the assay of adenylylcyclase, intracellular cyclic AMP, and cyclic AMP phosphodiesterase using tritium-labeled substrates. Anal. Biochem. 203:1992;32-76.
2. Butour J.-L., Moisand C., Mazarguil H., Mollereau C., Meunier J.-C. Recognition and activation of the opioid receptor-like ORL1 receptor by nociceptin, nociceptin analogs and opioids. Eur. J. Pharmacol. 321:1997;97-103.
3. Guerrini R., Calo G., Rizzi A., Bigoni R., Bianchi C., Salvadori S., Regoli D. A new selective antagonist of the nociceptin receptor. Br. J. Pharmacol. 123:1998;163-165.
4. + channel in Xenopus oocytes. Br. J. Pharmacol. 120:1997;986-987.
5. Meunier J.-C. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor. Eur. J. Pharmacol. 340:1997;1-15.
6. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J.-L., Guillemot J.-C., Ferrara P., Monsarrat B., Mazarguil H., Vassart G., Parmentier M., Costentin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 377:1995;532-535.
7. Mollereau C., Parmentier M., Mailleux P., Butour J.-L., Moisand C., Chalon P., Caput D., Vassart G., Meunier J.-C. ORL1, a novel member of the opioid receptor family: cloning, functional expression and localization. FEBS Lett. 341:1994;33-38.
8. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma F.J. Jr., Civelli O. Orphanin FQ, a neuropeptide that activates an opioid like G protein-coupled receptor. Science. 270:1995;792-794.